The CIP participants in this study were all bi-allelic compound heterozygotes, and all of their mutations have previously been characterized and shown to abolish almost all Nav1.7-driven sodium currents. This evidence concerns the gene SCN9A and hereditary sensory and autonomic neuropathy.